We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry May Support User Fee Hikes to Improve Risk Messages
Industry May Support User Fee Hikes to Improve Risk Messages
December 14, 2005
Although the drug industry has been critical of the FDA’s proposal to raise prescription drug user fees to fund activities not directly related to application reviews, industry representatives confirmed this month that they may support fee hikes to pay for improved risk communication.